Replies to post #100286 on Amarantus Bioscience Holdings Inc (AMBS)

[JJAAMMAANN]

NT,
I think Gerald was reading your post....or at least I hope he was!

Further, as we continue the build out of Amarantus Diagnostics, our diagnostic division, these additional rights coupled with plans in process to re-launch development for our NuroPro diagnostic blood test for Parkinson's disease, will bolster our diagnostic division as a potentially stand-alone corporate entity in the future.

http://ir.stockpr.com/amarantus/company-news/detail/1254/amarantus-acquires-additional-rights-to-lympro-test-from-memory-dx

In My Personal Opinion Of Course!
Long AMBS!